CPI Logo-Color.png
Constellation Pharmaceuticals Provides Interim Update of Data for CPI-0610 in ASCO and EHA Abstracts
May 16, 2019 09:00 ET | Constellation Pharmaceuticals , Inc.
Data published in two abstracts suggest that CPI-0610 may have potential disease-modifying effects in treating myelofibrosis All ten evaluable patients experienced spleen volume reductions...
Geron-logo-black-xsmall.png
Geron Provides Imetelstat Program Update
May 16, 2019 08:00 ET | Geron Corporation
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today provided an update to its 2019 corporate objectives for the imetelstat program. “2019 is off to a good...
Geron-logo-black-xsmall.png
Geron Continues to Build Senior Leadership of Its Development Team
May 16, 2019 06:00 ET | Geron Corporation
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it is continuing to build the senior leadership of its development team with the addition...
CPI Logo-Color.png
Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results
May 08, 2019 16:15 ET | Constellation Pharmaceuticals , Inc.
Company to present an interim update of data from the MANIFEST clinical trial of CPI-0610 at ASCO on June 3 and at EHA on June 15Related investor event at ASCO to be held on June 4 ...
Geron-logo-black-xsmall.png
Geron Corporation Reports First Quarter 2019 Financial Results
May 02, 2019 16:17 ET | Geron Corporation
MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2019. As of the quarter-end, the Company...
Geron-logo-black-xsmall.png
Geron Expands Senior Leadership of Its Development Team
April 18, 2019 08:00 ET | Geron Corporation
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team’s senior leadership with the addition of three highly...
Geron-logo-black-xsmall.png
Geron to Present at Needham Healthcare Conference
April 02, 2019 16:30 ET | Geron Corporation
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a...
Geron-logo-black-xsmall.png
Geron Appoints Two New Independent Board Members
March 28, 2019 08:00 ET | Geron Corporation
MENLO PARK, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointments of Dawn C. Bir and Elizabeth G. O’Farrell as independent members of its Board...
Geron-logo-black-xsmall.png
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
March 07, 2019 16:05 ET | Geron Corporation
MENLO PARK, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and full year ended December 31, 2018 and recent...
Geron-logo-black-xsmall.png
Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
February 28, 2019 16:30 ET | Geron Corporation
MENLO PARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2018 financial results after the market...